Total Funding
29
1
Total FundingSeed raised
Growth Score
-5 pts
Heat Score
-55 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
685760
IDP Pharma is a first in class drug for multiple mieloma treatment, to set up new discovery programs.
- Laura Nevola: CSOPast Role: Yale University, Visiting Assistant in Research
- Past Role: Barcelona Supercomputing Center, Senior Scientist
About the Company
IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins (IDPs). They are currently focused on exploiting new mechanisms of action to treat cancer diseases. Multiple myeloma is one of their priorities.
IDP Pharma's
efforts are directed towards promoting a real shift in cancer therapies to improve the lives of patients. To this end, the company has built an extraordinary committed team of experts in the field, supported by a professional advisory board, including IDPs and diseases experts, and business professionals.
